Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence?
Objectives. Diabetes mellitus is an endemic disease of the current era. It is important to treat it properly. All antidiabetic medications have side effects and various safety profiles.
Guardado en:
Autores principales: | Khoury Johad, Andrawus Elias, Bishop Boaz Y., Azzam Zaher S. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15ae93281d324e408fdfd2dd11952312 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011) -
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
por: Knop FK, et al.
Publicado: (2010) -
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
por: Megan Rodgers, et al.
Publicado: (2021) -
The associations of incretin hormone concentration with gestational diabetes mellitus
por: Tatiana V. Saprina, et al.
Publicado: (2016) -
Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
por: Howell R, et al.
Publicado: (2019)